Seaside Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Pangea Biopangeabio.cominSeries A · Sep 2023
Pangea Bio develops therapies targeting central nervous system and mental health disorders by activating the TrkB receptor pathway to promote neuronal survival and synaptic plasticity.
BiotechDeep TechDigital Health
Co-investorsMetaplanetNO LABEL VENTURESVox CapitalXEIA Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.